These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15385046)

  • 1. Cases of surgery in high-responder haemophilia patients.
    Goudemand J; Tagariello G; Lopaciuk F
    Haemophilia; 2004 Sep; 10 Suppl 2():46-9. PubMed ID: 15385046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery in haemophilic patients with inhibitor: 20 years of experience.
    Quintana-Molina M; Martínez-Bahamonde F; González-García E; Romero-Garrido J; Villar-Camacho A; Jiménez-Yuste V; Fernández-Bello I; Hernández-Navarro F
    Haemophilia; 2004 Sep; 10 Suppl 2():30-40. PubMed ID: 15385044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
    Takedani H; Kawahara H; Kajiwara M
    Haemophilia; 2010 Mar; 16(2):290-5. PubMed ID: 19925628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to manage invasive procedures in children with haemophilia.
    Ljung RC; Knobe K
    Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective study.
    Auerswald G; Bade A; Haubold K; Overberg D; Masurat S; Moorthi C
    Haemophilia; 2013 May; 19(3):438-44. PubMed ID: 23279056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies.
    Négrier C; Lienhart A; Numerof R; Stephens D; Wong WY; Baghaei F; Yee TT
    Haemophilia; 2013 May; 19(3):e143-50. PubMed ID: 23282031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.
    Habermann B; Hochmuth K; Hovy L; Scharrer I; Kurth AH
    Haemophilia; 2004 Nov; 10(6):705-12. PubMed ID: 15569165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching haemophilia products and inhibitor risk: a United States' perspective.
    Nance D; Rodgers GM
    Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
    Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
    Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven.
    Johannessen M; Andreasen RB; Nordfang O
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):239-42. PubMed ID: 10870803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of mild haemophilia: a 30-year single centre experience.
    Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
    Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of pharmacologic options for the treatment of persons with hemophilia.
    Franchini M; Mannucci PM
    Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor.
    Hayashi T; Tanaka I; Shima M; Yoshida K; Fukuda K; Sakurai Y; Matsumoto T; Giddings JC; Yoshioka A
    Haemophilia; 2004 Jul; 10(4):397-400. PubMed ID: 15230956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.
    Tjønnfjord GE; Brinch L; Gedde-Dahl T; Brosstad FR
    Haemophilia; 2004 Mar; 10(2):174-8. PubMed ID: 14962207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.
    Lauroua P; Ferrer AM; Guérin V
    Haemophilia; 2009 Nov; 15(6):1300-7. PubMed ID: 19659794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients).
    Rodriguez-Merchan EC; Quintana M; Jimenez-Yuste V; Hernández-Navarro F
    Haemophilia; 2007 Sep; 13(5):613-9. PubMed ID: 17880452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.
    Dargaud Y; Lienhart A; Meunier S; Hequet O; Chavanne H; Chamouard V; Marin S; Negrier C
    Haemophilia; 2005 Sep; 11(5):552-8. PubMed ID: 16128902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.